AGLE : Insider Transactions for Aeglea Biotherapeutics, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Aeglea Biotherapeutics, Inc. (AGLE)

$0.60 0.00 (0.00%) as of 4:30 Thu 9/7

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

61,170,000

Market Cap:

36.74(M)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$0.1064 - $0.6766

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Aeglea BioTherapeutics is a holding company. Through its subsidiaries, Co. is a biotechnology company developing human enzyme therapeutics for people with rare metabolic diseases. Co.'s development programs include: Pegzilarginase in Arginase 1 Deficiency, which is a recombinant human Arginase 1 that enzymatically degrades the amino acid arginine and improves the stability and arginine-degrading activity of the enzyme in human plasma; and AGLE-177 in Homocystinuria, which is a PEGylated, or polyethylene glycol modified, human enzyme engineered to degrade free homocysteine and homocystine. Co.'s preclinical pipeline includes cystinuria program to reduce plasma cystine and cysteine levels.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	118,200
Total Buy Value	$0	$0	$0	$70,494
Total People Bought	0	0	0	2
Total Buy Transactions	0	0	0	2
Total Shares Sold	0	3,435,480	3,435,480	3,435,480
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	1	1	1
Total Sell Transactions	0	1	1	1
End Date	2024-02-11	2023-11-10	2023-05-12	2022-05-12

Adjust Filter Settings

Records found: 92

Page 3 of 4

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

• • •

2018-05-10

4

S

$10.13

$230,204

D/D

(22,725)

2,194,864

-

• • •

2018-05-09

4

S

$10.11

$517,935

D/D

(51,230)

2,217,589

-

• • •

2018-05-08

4

S

$10.03

$266,367

D/D

(26,557)

2,268,819

-

• • •

2018-05-07

4

S

$10.11

$157,190

D/D

(15,548)

2,295,376

-

President & CEO

• • –

2018-02-15

4

B

$6.02

$12,040

D/D

2,000

94,793

2.81

-

Interim CEO

• • –

2018-02-15

4

OE

$5.46

$83,052

D/D

15,211

50,620

-

Interim CEO

• • –

2017-12-08

4

B

$5.07

$3,039

D/D

600

35,409

2.73

-

Interim CEO

• • –

2017-12-07

4

B

$4.99

$13,967

D/D

2,800

34,809

2.81

-

Interim CEO

• • –

2017-12-06

4

B

$4.92

$24,072

D/D

4,888

32,009

2.81

-

Director

– • –

2017-12-05

4

B

$4.93

$24,976

D/D

5,065

27,121

2.39

-

York Charles N Ii

Chief Financial Officer and VP

• – –

2017-12-05

4

B

$4.76

$48,700

D/D

10,241

34,787

2.74

-

Director

– • –

2017-12-04

4

B

$4.98

$39,624

D/D

7,956

22,056

2.39

-

York Charles N Ii

Chief Financial Officer and VP

• – –

2017-12-04

4

B

$4.97

$16,197

D/D

3,259

24,546

2.74

-

Director

– • –

2017-12-01

4

B

$4.53

$18,578

D/D

4,100

14,100

2.39

-

York Charles N Ii

Chief Financial Officer and VP

• – –

2017-12-01

4

B

$4.59

$29,855

D/D

6,500

21,287

2.74

-

York Charles N Ii

Chief Financial Officer and VP

• – –

2017-08-15

4

B

$2.52

$4,929

D/D

1,959

14,787

2.66

-

10% Owner

– – •

2017-02-21

4

B

$5.36

$37,520

I/I

7,000

1,469,524

1.5

-

10% Owner

– – •

2017-02-17

4

B

$5.19

$372,642

I/I

71,800

1,462,524

1.5

-

10% Owner

– – •

2017-02-16

4

B

$5.04

$153,720

I/I

30,500

1,390,724

1.5

-

York Charles N Ii

Chief Financial Officer and VP

• – –

2017-02-15

4

B

$4.28

$8,568

D/D

2,000

12,828

2.74

-

York Charles N Ii

Chief Financial Officer and VP

• – –

2016-08-15

4

B

$3.99

$7,974

D/D

2,000

10,828

2.74

-

10% Owner

– – •

2016-04-12

3

IO

$0.00

$0

I/I

0

1,360,224

-

Shanafelt Armen

10% Owner

– – •

2016-04-12

4/A

A

$0.00

$0

I/I

2,010,924

2,068,543

-

10% Owner

– – •

2016-04-12

4

B

$10.00

$5,000,000

I/I

500,000

2,568,543

1.5

-

10% Owner

– – •

2016-04-12

4

A

$0.00

$0

I/I

2,010,924

2,068,543

-

92 Records found	1 2 3 4	Page 3 of 4

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.